Research Topics
| Thomas ZilliSummaryCountry: Italy Publications
|
Detail Information
Publications
Dose escalation study with two different hypofractionated intensity modulated radiotherapy techniques for localized prostate cancer: acute toxicityThomas Zilli
Service de radio oncologie, Hopitaux Universitaires de Geneve, Geneva, Switzerland
Technol Cancer Res Treat 9:263-70. 2010..02). Dose escalation with either 14 _ 4 Gy or 15 _ 4 Gy delivered with two different IMRT techniques is feasible and is associated with a tolerable acute toxicity...
Guillain-Barré syndrome as an atypical manifestation of an esophageal carcinomaT Zilli
Department of Radiation Oncology, Geneva University Hospital, 1211, Geneva 14, Switzerland
Neurol Sci 32:151-3. 2011..A GBS neuropathy of undetermined origin may be associated with an underlying tumor and esophageal cancer has to be considered in the differential diagnosis...
Twice-weekly hypofractionated intensity-modulated radiotherapy for localized prostate cancer with low-risk nodal involvement: toxicity and outcome from a dose escalation pilot studyThomas Zilli
Service de radio oncologie, Hopitaux Universitaires de Geneve, Geneva, Switzerland
Int J Radiat Oncol Biol Phys 81:382-9. 2011..To evaluate the toxicity and preliminary outcome of patients with localized prostate cancer treated with twice-weekly hypofractionated intensity-modulated radiotherapy (IMRT)...
Recurrence pattern after [(18)F]fluoroethyltyrosine-positron emission tomography-guided radiotherapy for high-grade glioma: a prospective studyDamien C Weber
Department of Radiation Oncology, and Department of Radiation Oncology, University of Geneva, Geneva, Switzerland
Radiother Oncol 93:586-92. 2009..To assess the failure pattern observed after (18)F fluoroethyltyrosine (FET) planning after chemo- and radiotherapy (RT) for high-grade glioma...
Intensity modulated proton and photon therapy for early prostate cancer with or without transperineal injection of a polyethylen glycol spacer: a treatment planning comparison studyDamien C Weber
Department of Radiation Oncology, Geneva University Hospital, Geneva, Switzerland
Int J Radiat Oncol Biol Phys 84:e311-8. 2012..We assessed the dosimetric impact of this spacer with advanced delivery RT techniques, including intensity modulated RT (IMRT), volumetric modulated arc therapy (VMAT), and intensity modulated proton beam RT (IMPT)...
Impact of 18F-FDG PET/CT on target volume delineation in recurrent or residual gynaecologic carcinomaHansjorg Vees
Division of Radiation Oncology, Geneva University Hospital, Geneva 14 CH 1211, Switzerland
Radiat Oncol 7:176. 2012..To evaluate the impact of 18F-FDG PET/CT on target volume delineation in gynaecological cancer...
Unilateral radiotherapy for tonsil cancer: potential dose distribution optimization with a simple two-field intensity-modulated radiation therapy beam arrangementThomas Zilli
Department of Radiation Oncology, Geneva University Hospital, Geneva, Switzerland
Radiother Oncol 94:334-8. 2010..To evaluate the feasibility and dosimetric optimization potential of a unilateral two-field intensity-modulated radiotherapy (IMRT) technique in the curative treatment of lateralized tonsil cancer...
Target volume definition in high-risk prostate cancer patients using sentinel node SPECT/CT and 18 F-choline PET/CTHansjorg Vees
Division of Radiation Oncology, University Hospital, Geneva, Switzerland
Radiat Oncol 7:134. 2012..To assess the influence of sentinel lymph nodes (SNs) SPECT/CT and 18 F-choline (18 F-FCH) PET/CT in radiotherapy (RT) treatment planning for prostate cancer patients with a high-risk for lymph node (LN) involvement...
Intensity modulated radiation therapy or stereotactic fractionated radiotherapy for infratentorial ependymoma in children: a multicentric studyDamien C Weber
Département de l Imagerie Médical et Science de l Information, Geneva University Hospital, 1211, Geneva 14, Switzerland
J Neurooncol 102:295-300. 2011..Larger series of patients treated with these two modalities will be necessary to more fully evaluate these delivery techniques...
Node-negative T1-T2 anal cancer: radiotherapy alone or concomitant chemoradiotherapy?Thomas Zilli
Department of Radiation Oncology, Hopitaux Universitaires de Geneve, Switzerland
Radiother Oncol 102:62-7. 2012..To evaluate the influence of concomitant chemotherapy on loco-regional control (LRC) and cancer-specific survival (CSS) in patients with T1-T2 N0 M0 anal cancer treated conservatively by primary radiotherapy (RT)...
[(18)F]Fluoroethyltyrosine- positron emission tomography-guided radiotherapy for high-grade gliomaDamien C Weber
Department of Radiation Oncology, Geneva University Hospital, Geneva, Switzerland
Radiat Oncol 3:44. 2008....
